Eosinophilic Esophagitis MarketThe global demand for Eosinophilic Esophagitis Market is projected to increase at a CAGR of 28% during the forecast period between 2023 and 2033, reaching a total of US$ 2,032.8 Billion by 2033, according to a report from Future Market Insights (FMI). From 2018 to 2023, sales witnessed.
SAN ANTONIO — A high proportion of patients with eosinophilic esophagitis also had simultaneous atopic or allergic comorbid conditions, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.Eosinophilic esophagitis (EoE) is a chronic, progressive type II inflammatory disease, Marc E. Rothenberg, MD, PhD, director of the Cincinnati Center for
Increasing cases of Inflammatory Bowel Disease (IBD) in various regions lead to increased demand for advanced diagnostic and treatment in the Inflammatory.